Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (19)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L. Xu, Omar Abdel-Wahab, Justin Taylor, David P. Steensma, Daniel T. Starczynowski, Mikkael A. Sekeres, Guillermo Sanz, David A. Sallman, Gail J. Roboz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Stephen D. Nimer, Aziz Nazha, Ravi Majeti, Sanam Loghavi, Richard F. Little, Alan F. List, Tae Kon Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Steven D. Gore, Peter Greenberg, Maria E. Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Rena Buckstein, Andrew M. Brunner, Jacqueline Boultwood, Uma Borate, Rafael Bejar, John M. Bennett, Andrew H. Wei, Valeria Santini, Michael R. Savona & Amer M. Zeidan. (2023) Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS). Blood Reviews 62, pages 101128.
Crossref
Crossref
Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob Appelbaum, Anna B. Halpern, Pamela S. Becker, Roland B. Walter, Elihu Estey & Mary-Elizabeth Percival. (2023) Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms. Leukemia 37:9, pages 1912-1914.
Crossref
Crossref
Giulio Trapè, Gioia De Angelis, Marco Morucci, Michela Tarnani, Cinzia De Gregoris, Ambra Di Veroli, Valentina Panichi, Giuseppe Topini, Loredana Bassi, Raffaella Isidori, Monica Poscente, Vincenza Innocenti, Elisa Emanueli Cippitelli, Roberta Talucci, Silvia Bertelli, Alessandra Crocicchia, Annalisa Lippi, Giulia Pezzuti, Michela Fuschino, Raffaella Randi, Cristina Mastini, Silvia Ciambella, Gloria Pessina, Marco Montanaro & Roberto Latagliata. (2023) Treatment in patients with acute myeloid leukemia/high‐risk myelodysplastic syndrome with hypomethylating agents: Day‐hospital management compared to home care setting. European Journal of Haematology 111:2, pages 311-317.
Crossref
Crossref
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner, Rena Buckstein, Hetty E. Carraway, Jane E. Churpek, Naval G. Daver, Matteo Giovanni Della Porta, Amy E. DeZern, Pierre Fenaux, Maria E. Figueroa, Steven D. Gore, Elizabeth A. Griffiths, Stephanie Halene, Robert P. Hasserjian, Christopher S. Hourigan, Tae Kon Kim, Rami Komrokji, Vijay K. Kuchroo, Alan F. List, Sanam Loghavi, Ravindra Majeti, Olatoyosi Odenike, Mrinal M. Patnaik, Uwe Platzbecker, Gail J. Roboz, David A. Sallman, Valeria Santini, Guillermo Sanz, Mikkael A. Sekeres, Maximilian Stahl, Daniel T. Starczynowski, David P. Steensma, Justin Taylor, Omar Abdel-Wahab, Mina L. Xu, Michael R. Savona, Andrew H. Wei & Amer M. Zeidan. (2023) Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS). Blood Reviews 60, pages 101072.
Crossref
Crossref
Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Laila Terkawi, Hussein Awada, Olisaemeka D. Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kutoba, Minako Mori, Ben Ponvilawan, Bayan Al-Share, Bhumika J. Patel, Hetty E. Carraway, Jacob Scott, Suresh K. Balasubramanian, Taha Bat, Yazan Madanat, Mikkael A. Sekeres, Torsten Haferlach, Valeria Visconte & Jaroslaw P. Maciejewski. (2023) Molecular patterns identify distinct subclasses of myeloid neoplasia. Nature Communications 14:1.
Crossref
Crossref
Jan Philipp Bewersdorf, Zhuoer Xie & Amer M. Zeidan. (2023) Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment. The Cancer Journal 29:3, pages 195-202.
Crossref
Crossref
Phaedon D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou & Theodoros Karantanos. (2023) Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. International Journal of Molecular Sciences 24:5, pages 5018.
Crossref
Crossref
Rory M. Shallis, Naval G. Daver, Jessica K. Altman, Robert P. Hasserjian, Hagop M. Kantarjian, Uwe Platzbecker, Valeria Santini, Andrew H. Wei, David A. Sallman & Amer M. Zeidan. (2022)
TP53
‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity
. Cancer 129:2, pages 175-180.
Crossref
Crossref
Robert P. Hasserjian, Attilio Orazi, Alberto Orfao, Maria Rozman & Sa A. Wang. (2022) The International Consensus Classification of myelodysplastic syndromes and related entities. Virchows Archiv 482:1, pages 39-51.
Crossref
Crossref
Amer M. Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M. Bennett, Uma Borate, Andrew M. Brunner, Hetty Carraway, Jane E. Churpek, Naval G. Daver, Matteo Della Porta, Amy E. DeZern, Fabio Efficace, Pierre Fenaux, Maria E. Figueroa, Peter Greenberg, Elizabeth A. Griffiths, Stephanie Halene, Robert P. Hasserjian, Christopher S. Hourigan, Nina Kim, Tae Kon Kim, Rami S. Komrokji, Vijay Kutchroo, Alan F. List, Richard F. Little, Ravi Majeti, Aziz Nazha, Stephen D. Nimer, Olatoyosi Odenike, Eric Padron, Mrinal M. Patnaik, Gail J. Roboz, David A. Sallman, Guillermo Sanz, Maximilian Stahl, Daniel T. Starczynowski, Justin Taylor, Zhuoer Xie, Mina Xu, Michael R. Savona, Andrew H. Wei, Omar Abdel-Wahab & Valeria Santini. (2022) Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. Leukemia 36:12, pages 2939-2946.
Crossref
Crossref
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans-Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso-Ramos, Jorge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S. Hobbs, Ronald Hoffman, Elias J. Jabbour, Jean-Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L.-C. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte Niemeyer, Olatoyosi M. Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P. Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A. Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner & Ayalew Tefferi. (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140:11, pages 1200-1228.
Crossref
Crossref
Hartmut Döhner, Andrew H. Wei, Frederick R Appelbaum, Charles Craddock, Courtney D. DiNardo, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Lucy A. Godley, Robert P. Hasserjian, Richard A. Larson, Ross L. Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert J Ossenkoppele, Christoph Röllig, Jorge Sierra, Eytan M. Stein, Martin S. Tallman, Hwei-Fang Tien, Jianxiang Wang, Agnieszka Wierzbowska & Bob Löwenberg. (2022) Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. Blood.
Crossref
Crossref
Rory M. Shallis, Jan P. Bewersdorf, Maximilian F. Stahl, Stephanie Halene & Amer M. Zeidan. (2022) Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?. Cancers 14:10, pages 2434.
Crossref
Crossref
Yajuan Gao, Mingnan Jia, Yueying Mao, Hao Cai, Xianyong Jiang, Xinxin Cao, Daobin Zhou & Jian Li. (2022) Distinct Mutation Landscapes Between Acute Myeloid Leukemia With Myelodysplasia-Related Changes and De Novo Acute Myeloid Leukemia. American Journal of Clinical Pathology 157:5, pages 691-700.
Crossref
Crossref
Qiujin Shen, Yahui Feng, Xiaowen Gong, Yujiao Jia, Qingyan Gao, Xiaokang Jiao, Saibing Qi, Xueou Liu, Hui Wei, Bingqing Huang, Ningning Zhao, Xiaoqiang Song, Yueshen Ma, Shihao Liang, Donglei Zhang, Li Qin, Ying Wang, Shiqiang Qu, Yao Zou, Yumei Chen, Ye Guo, Shuhua Yi, Gang An, Zengtao Jiao, Song Zhang, Linfeng Li, Jun Yan, Huijun Wang, Zhen Song, Yingchang Mi, Lugui Qiu, Xiaofan Zhu, Jianxiang Wang, Zhijian Xiao & Junren Chen. (2022) A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms. Cancer Research Communications 2:4, pages 258-276.
Crossref
Crossref
Xueyan Chen, Jonathan R. Fromm & Kikkeri N. Naresh. (2022) “Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward?. Leukemia 36:2, pages 327-332.
Crossref
Crossref
Elihu EsteyRobert P. Hasserjian & Hartmut Döhner. (2022) Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal. Blood 139:3, pages 323-332.
Crossref
Crossref
Sa A. Wang, Chi Young Ok, Annette S. Kim, Fabienne Lucas, Elizabeth A. Morgan, Beenu Thakral, Sanjay Patel, Valentina Nardi, Keyur M. Patel, Olga K. Weinberg & Robert P. Hasserjian. (2021) Myelodysplastic syndromes with no somatic mutations detected by next‐generation sequencing display similar features to myelodysplastic syndromes with detectable mutations. American Journal of Hematology 96:11.
Crossref
Crossref
Adam S. Zayac & John L. Reagan. (2021) Trials and Tribulations in the Frontline Treatment of Older Adults with Acute Myeloid Leukemia. Hemato 2:3, pages 515-544.
Crossref
Crossref